Top 10 Life Science Angel Investors in France in January 2026

Last updated: Jan 2026 A list of 10 angel investors that invest in Life science startups based in France. We rank investors based on the number of investments they made in Life science companies from France. We update this investor list every month.

Top 10 Life Science Angel Investors in France in January 2026

Investor	Life Science France investments
Andrew Nutter	2
Sylvain Zimmer	2
Bernard Majoie	1
Bertrand Jacquelot	1
Christophe Ricard	1
Sebastian Lombardo	1
Fidji Simo	1
Jacques Lewiner	1
Irwan Bello	1
Xavier Niel	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Andrew Nutter is a Co-Founder at Gama. He attended Stanford University.

Investment focus

Software, SaaS, Biotechnology
Seed, Pre-Seed, Funding Round
France, United Kingdom, United States

Portfolio highlights

Yavin — Yavin provides modern point-of-sale solutions for European merchants
Gama — Thanks to cheap, reliable and scalable solar sails, we are redefining deep space access.
EV Biotech — We design and optimise your precision fermentation strains and processes, tailored to your success.

Sylvain is a French software developer turned entrepreneur, conference organizer and angel investor.

Investment focus

Software, Financial Services, SaaS
Seed, Pre-Seed, Angel
France, United States, United Kingdom

Portfolio highlights

GOURMEY — We create sustainable cultivated meat delights for an uncompromising and conscious generation.
Waldo — The codeless way to quickly build a comprehensive test suite for teams who don't compromise on speed and quality.
TOTEM — A Totem is a place of sharing and conviviality in your office. This is an opportunity for your colleagues to get to know each other better, celebrate victories and defeats together, and build a solid culture.

Bernard Majoie - President @ Fournier-Majoie

Investment focus

Biotechnology, Medical, Health Care
Seed, Pre-Seed, Series A
France, Belgium

Portfolio highlights

reMYND — Driving the development of disease-modifying treatments
AgenT — AgenT develops the first blood diagnosis to detect Alzheimer's years before the onset of the irreversible symptoms.
PEP-Therapy — PEP-Therapy is a French biotechnology company developing first-in-class peptides as targeted therapies in oncology

Bertrand Jacquelot is the Founding President of Projim. He attended the University of Marne-la-Vallee.

Investment focus

E-Commerce, Information Technology, Food and Beverage
Pre-Seed, Seed, Angel
France, United States

Portfolio highlights

Bolk — Bolk provides autonomous bowl-making robotic canteen which producing warm meals, cold dishes and desserts from precooked ingredients.
Arkania — B2B API solution for brands to create and sell online NFTs directly on their platforms
Starton — Integrate blockchain technology this week. Focus on your vision, we handle blockchain complexity

Christophe Ricard CEO of OM Pharma

Investment focus

Life Science, Biotechnology, Medical Device
Seed, Series B
France

Portfolio highlights

Antabio — Antabio is a private biopharmaceutical company developing novel antibacterial resistance-breakers to treat drug-resistant infections in areas of highest unmet medical need.

Sebastian Lombardo - CEO @ Valtech

Investment focus

Apps, Internet, Lifestyle
Seed
France, United States

Portfolio highlights

Jop — A one-stop-shop for urban residents, Jop offers a variety of on-demand services in one convenient, easy-to-use platform. Customers can tap a screen and connect with a professional in their city, whether they are an expert at cleaning apartments, trimming mustaches, walking dogs, doing makeup, DJing, or mixing drinks. Instead of paying a company’soverhead, customers pay a Jopper. Once booked, Joppers arrive right at the customer’s doorstep, ready to work.Founded by Canel Frichet and Sebastian Lombardo, Jop was born as a platform to give people the opportunity to work directly for each other, as opposed to hiring through a company. Joppers set their own pricing and hours. Something else that sets JOP apart from other platforms in the on-demand space is that Joppers earn company equity, which is granted based on level of activity and performance on the platform.
Smart Immune — Smart Immune is a clinical-stage biotechnology company focused on developing the next generation of hematopoietic stem cell-based biotherapies to change the prognosis and life quality of patients with devastating diseases. The company's first cell therapy program is based on T cell progenitors or ProTcellsTM (CD7+/CD34-; CD5- cells)curative power to enable a short, polyclonal, and safe post-transplantation immune recovery. This program be completed by integrative developments from targeted conditioning to gene therapy and genome editing enabling clinicians to access new-generation treatments for a wide variety of inherited blood disorders and blood cancers.

Fidji Simo is the CEO and Chair of the Board of Directors of Instacart. She previously worked at Facebook as a Head of the Facebook App. Fidji Simo attended HEC Paris.

Investment focus

Software, Health Care, Internet
Seed, Series A, Series B
United States, United Kingdom, France

Portfolio highlights

Somite — Somite.ai is on a mission to transform the lives of millions of people by leveraging AI to produce human tissue for cell-based therapies.
Owner — Owner gives you the same tools that major national brands use to drive sales. Online ordering proven to grow sales. Mobile app with rewards. And more.
Orchid — Orchid is a reproductive technology startup that is capable of detecting rare genetic disorders. Orchid’s preconception system analyzes both partners’ genomes and assesses genetic predispositions to common diseases, including heart disease, stroke, schizophrenia, Alzheimer’s disease, breast cancer, and diabetes. Orchid results are developed withworld-class experts in reproductive medicine and genetics to give its clients the most accurate results.Orchid offers a “Couple Report” that utilizes an at-home saliva test to analyze each person’s genomes to detect the probability of genetic risks, then models how their DNA together will combine in a future child. If elevated risk is detected, Orchid provides insights to help couples monitor biomarkers, adapt their diet or elect for procedures, such as in vitro fertilization. It was founded by Noor Siddiqui in 2019 and is headquartered in San Francisco, California.

Jacques Lewiner - Member of the Board of Directors @ Axilum Robotics

Investment focus

Biotechnology, Medical, Health Care
Seed, Series C
France

Portfolio highlights

Cytoo — Pioneering muscle pathology research with our exclusive MyoScreen platform to accelerate drug target identification and therapeutic innovation.
Okomera — Automated 3D model drug testing of cancer biopsies prior to treatment. For precision and personalized medicine. The "test before you treat" solution for every oncologist and patient.

Irwan Bello is an individual investor.

Investment focus

Information Technology, Internet, Life Science
Seed, Pre-Seed
France, United States

Portfolio highlights

Okomera — Automated 3D model drug testing of cancer biopsies prior to treatment. For precision and personalized medicine. The "test before you treat" solution for every oncologist and patient.
Lutra AI — Lutra AI is to simplify complex tasks that specializes in workflows, created by the platform.
Twin — Twin Labs, offer an automated tool for repetitive operations, such as onboarding new staff to all internal systems.

Xavier Niel is based out of Paris, Ile-de-France and is the Co-Founder and CEO of NJJ Capital. Xavier previously worked at Worldnet as a Founder. Xavier Niel attended Saint Michel de Picpus Catholic private high school.